Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
AMPA= : α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP= : adenosine triphosphate; EAAT= : excitatory amino acid transporters; GABA= : γ-aminobutyric acid; GCI= : glial cytoplasmic inclusion; MS= : multiple sclerosis; MSA= : multiple system atrophy; NG2= : neuron glia 2; NO= : nitric oxide; NOS= : nitric oxide synthase; OPC= : oligodendrocyte progenitor cell; PDGF= : platelet-derived growth factor–α; PVL= : periventricular leukomalacia; TNF= : tumor necrosis factor. Oligodendrocytes are the myelin-producing cells in the CNS and are critical for function and survival of the axons. Oligodendrocytes and their precursors are highly susceptible to excitotoxic damage, oxidative stress, and effects of cytokines. Glutamate and other neurotransmitters triggering calcium (Ca2+) signaling have a major role in both normal oligodendrocyte development and oligodendrocyte injury in white matter disorders such as periventricular leukomalacia (PVL), multiple sclerosis (MS), ischemic stroke, traumatic brain or spinal injury, radiation necrosis, and leukodystrophies. Oligodendrocytes may also have a central role in multiple system atrophy (MSA). These topics have been extensively covered in several excellent reviews1–8 and some of the most salient points are summarized here. Oligodendrocytes originate from progenitor cells that express the NG2 (neuron glia 2) chondroitin sulfate proteoglycan and platelet-derived growth factor–α (PDGF-α) receptor in their cell membrane (figure 1). After migration, oligodendrocyte progenitor cells reach their destination and begin to differentiate; they upregulate expression of myelin proteins, increase the number and complexity of their processes, and begin to form membrane wraps around the axons.1 Figure 1 Structural organization and receptor distribution of oligodendrocytes and oligodendrocyte progenitor cells (OPCs) Oligodendrocytes originate from progenitor cells that express the neuron glia 2 (NG2) chondroitin sulfate proteoglycan. Oligodendrocytes and their precursors express AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), kainate, and NMDA receptors for glutamate and adenosine triphosphate (ATP)–gated P2 × 7 receptors. AMPA/kainate receptors are predominantly expressed in the cell body and NMDA receptors in the myelinating processes. The AMPA, kainate, and NMDA receptors are permeable to calcium (Ca2+). The NG2+ glia include OPCs that receive excitatory and inhibitory synaptic inputs from myelinated or unmyelinated axons and extend processes to the nodes of Ranvier. Glutamate may also be released from reverse action of the excitatory amino acid transporters (EAAT) unexpressed both in the axons and …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Papp, M. I., & Lantos, P. L. (1994) · Brain · doi:10.1093/brain/117.2.235 · Cited by 389
Edgar, J. M., McLaughlin, M., Yool, D., Zhang, S.-C., Fowler, J. H., Montague, P., Barrie, J. A., McCulloch, M. C., Duncan, I. D., Garbern, J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312012 · Cited by 328
Shults, C. W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3527-05.2005 · Cited by 254
Stefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P. J., & Wenning, G. K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62307-3 · Cited by 208
Cited by
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Rüb, U., Schöls, L., Paulson, H., Auburger, G., Kermer, P., Jen, J. C., Seidel, K., Korf, H.-W., & Deller, T. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.01.001 · Cited by 346
Weidenheim, K. M., Dickson, D. W., & Rapin, I. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.07.006 · Cited by 156
Cordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98
Iron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
“…in animal studies will translate to humans as studies indicate that the expression or response of glutamate receptors in human oligodendrocytes may be substantially different (lower expression levels and resistant to excitotoxicity) from those in animals (Wosik et al., 2004; Benarroch, 2009).”
BackgroundInfluential
Metadata
- Authors
- Benarroch, E. E.
- Venue
- Neurology
- Published
- 2009-05-19
- Volume
- 72
- Issue
- 20
- Pages
- 1779-1785
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2090915843
- Cited by
- 81
- References
- 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181a6b123
- The paper
- Benarroch, E. E. (2009). Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. Neurology. https://doi.org/10.1212/wnl.0b013e3181a6b123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.